AKTX Akari Therapeutics enters strategic research collaboration with Whitehawk Therapeutics Akari Therapeutics - Co and Whitehawk to conduct

AKTX Akari Therapeutics enters strategic research collaboration with Whitehawk Therapeutics Akari Therapeutics - Co and Whitehawk to conduct preclinical studies of ph1 payload with top1i Adc platform - Collaboration to commence immediately with interim data updates anticipated